What they were paid
Dianthus Therapeutics Director Compensation Table · all 2 fiscal years held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $87,311 | — | $172,476 | — | $259,787 |
| FY2024 | $70,500 | — | $182,408 | — | $252,908 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Dianthus Therapeutics, Inc. DEF 14A filed April 9, 2026, accession 0001690585-26-000012, and prior-year filings. Open the filing on EDGAR.
That is Alison F. Lawton’s FY2025 figure, as filed. The FY2026 figure the day it is filed: one email, nothing else.
Saved. One email when Alison F. Lawton’s next annual disclosure lands here, with the figure.
One email when Alison F. Lawton’s next annual disclosure is on this page, with the figure. Nothing else is sent.
Get the Dianthus Therapeutics Board Governance Report
$259,787 Alison F. Lawton, FY2025 total director compensation
$499
The free page is the headline figures. The board report is director pay, board composition and committee fees assembled into the same kind of document.
Data as of April 9, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).
How this board is paid
company policy · FY2025Dianthus Therapeutics pays directors a $40,000 cash retainer and $12,500 in Options.
Committees
FY2025 · as the proxy prints themAudit · Nominating/Governance (Chair)
The rest of the Dianthus Therapeutics board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Anne McGeorge | Independent Director | $232,382 |
| Jonathan Violin, Ph.D | Independent Director | $217,476 |
| Marino Garcia | Director | — |
| Paula Soteropoulos | Independent Director | $231,787 |
| Simon Read, Ph.D | Independent Director | $382,309 |
| Steven Romano, M.D | Independent Director | $225,647 |
| Sujay Kango | Independent Director | $418,860 |
The full Dianthus Therapeutics compensation record
free company briefThis page is one director within Dianthus Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.
Peer companies
named in the Dianthus Therapeutics proxy · each links to its own free briefTrack this executive's pay every filing: join the Pro seat waitlist
Velarion Pro: every company page, peer tools and exports, one seat
Order DNTH
Pick the report, add the email the receipt and the PDF go to, and pay by card on Stripe.